Susceptibility loci for pancreatic cancer in the Brazilian population
- PMID: 33879152
- PMCID: PMC8056496
- DOI: 10.1186/s12920-021-00956-5
Susceptibility loci for pancreatic cancer in the Brazilian population
Abstract
Background: Pancreatic adenocarcinoma (PA) is a very aggressive cancer and has one of the poorest prognoses. Usually, the diagnosis is late and resistant to conventional treatment. Environmental and genetic factors contribute to the etiology, such as tobacco and alcohol consumption, chronic pancreatitis, diabetes and obesity. Somatic mutation in pancreatic cancer cells are known and SNP profile by GWAS could access novel genetic risk factors for this disease in different population context. Here we describe a SNP panel for Brazilian pancreatic cancer, together with clinical and epidemiological data.
Methods: 78 pancreatic adenocarcinoma and 256 non-pancreatic cancer subjects had 25 SNPs genotyped by real-time PCR. Unconditional logistic regression methods were used to assess the main effects on PA risk, using allelic, co-dominant and dominant inheritance models.
Results: 9 SNPs were nominally associated with pancreatic adenocarcinoma risk, with 5 of the minor alleles conferring protective effect while 4 related as risk factor. In epidemiological and clinical data, tobacco smoking, diabetes and pancreatitis history were significantly related to pancreatic adenocarcinoma risk. Polygenic risk scores computed using the SNPs in the study showed strong associations with PA risk.
Conclusion: We could assess for the first time some SNPs related with PA in Brazilian populations, a result that could be used for genetic screening in risk population such as familial pancreatic cancer, smokers, alcohol users and diabetes patients.
Keywords: Association study; Brazil; Genetic susceptibility; Pancreatic cancer; SNP.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Prediction model for pancreatic cancer risk in the general Japanese population.PLoS One. 2018 Sep 7;13(9):e0203386. doi: 10.1371/journal.pone.0203386. eCollection 2018. PLoS One. 2018. PMID: 30192808 Free PMC article.
-
An evaluation study of reported pancreatic adenocarcinoma risk-associated SNPs from genome-wide association studies in Chinese population.Pancreatology. 2017 Nov-Dec;17(6):931-935. doi: 10.1016/j.pan.2017.09.009. Epub 2017 Sep 27. Pancreatology. 2017. PMID: 28988600
-
Association study of type 2 diabetes genetic susceptibility variants and risk of pancreatic cancer: an analysis of PanScan-I data.Cancer Causes Control. 2011 Jun;22(6):877-83. doi: 10.1007/s10552-011-9760-5. Epub 2011 Mar 29. Cancer Causes Control. 2011. PMID: 21445555 Free PMC article.
-
The role of genetic factors in the etiology of pancreatic adenocarcinoma: an update.Cancer Invest. 2001;19(1):65-75. doi: 10.1081/cnv-100000076. Cancer Invest. 2001. PMID: 11291558 Review.
-
Germline genetic variability in pancreatic cancer risk and prognosis.Semin Cancer Biol. 2022 Feb;79:105-131. doi: 10.1016/j.semcancer.2020.08.003. Epub 2020 Aug 18. Semin Cancer Biol. 2022. PMID: 32818625 Review.
Cited by
-
Do Polygenic Risk Scores Add to Clinical Data in Predicting Pancreatic Cancer? A Scoping Review.Cancer Epidemiol Biomarkers Prev. 2023 Nov 1;32(11):1490-1497. doi: 10.1158/1055-9965.EPI-23-0468. Cancer Epidemiol Biomarkers Prev. 2023. PMID: 37610426 Free PMC article.
-
Utility of Polygenic Risk Scores (PRSs) in Predicting Pancreatic Cancer: A Systematic Review and Meta-Analysis of Common-Variant and Mixed Scores with Insights into Rare Variant Analysis.Cancers (Basel). 2025 Jan 13;17(2):241. doi: 10.3390/cancers17020241. Cancers (Basel). 2025. PMID: 39858023 Free PMC article. Review.
-
Circulating Cell-Free Nucleic Acids as Biomarkers for Diagnosis and Prognosis of Pancreatic Cancer.Biomedicines. 2023 Apr 1;11(4):1069. doi: 10.3390/biomedicines11041069. Biomedicines. 2023. PMID: 37189687 Free PMC article. Review.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical